Is angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy protective against prostate cancer?

Oncotarget · 2016 · PMC4872747 · PMID 26760503

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

[ 17 ], which led to a borderline significant estimate (RR 0.92, 95 % CI 0.84-1.00), the other eight pooled RRs remained statistically significant.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.